Search For "sii"
SII aims to supply 21.50 crore doses of Covishield vaccine in October: Sou
Updated : 4 years, 5 months ago IST
Pune (Maharashtra) [India], October 1 (ANI): Serum Institute of India (SII) has supplied 78 crore doses of its COVID-19 vaccine Covishield so far and its target is to supply almost 21.50 crore doses in the month of October, informed the sources to ANI on Friday.
Read More
You, I & Humm, a fictional novel enters the Best Sellers Rank
Updated : 4 years, 6 months ago IST
Hyderabad (Telangana) [India], September 23 (ANI/Heylin Spark): You, I & Humm- an anecdotal novel written by Chaithanya and Lavanya is keeping the readers glued through its storyline.
Read More
'OhBaby a gift that keeps on giving', Samantha Akkineni on bagging Best Ac
Updated : 4 years, 6 months ago IST
Mumbai (Maharashtra) [India], September 19 (ANI): Actor Samantha Akkineni expressed her gratitude for bagging the Best Actress in a Leading Role (Telugu) award for 'Oh! Baby' at The South Indian International Movie Awards.
Read More
SII announces strategic partnership with Biocon Biologics
Updated : 4 years, 6 months ago IST
New Delhi [India], September 17 (ANI): Hoping to strengthen India's position as a global vaccine and biologics manufacturing powerhouse, COVID-19 vaccine Covishield maker Serum Institute of India (SII) announced a strategic alliance with biopharmaceutical company Biocon Biologics Limited (BB
Read More
PM Modi, Mamata Banerjee, Adar Poonawala in Time's 100 Most Influential Pe
Updated : 4 years, 6 months ago IST
New Delhi [India], September 15 (ANI): Prime Minister Narendra Modi, West Bengal Chief Minister Mamata Banerjee and Serum Institute of India (SII) CEO Adar Poonawala have been listed in the Time Magazine's 100 Most Influential People of 2021.
Read More
SII acquires 50 pc stake in pharma packaging firm Schott Kaisha
Updated : 4 years, 7 months ago IST
Pune (Maharashtra) [India], August 17 (ANI): Serum Institute of India (SII) acquired a 50 pc stake of SCHOTT Kaisha to become SCHOTT's joint venture partner and secure pharma packaging supply, Serum Institute of India announced on Tuesday.
Read More
Mixing two different vaccines of COVID-19 is very risky: Cyrus Poonawalla
Updated : 4 years, 7 months ago IST
Pune (Maharashtra) [India], August 14 (ANI): Mixing two different vaccines of COVID-19 is a very risky decision and it is must be discouraged, said Cyrus Poonawalla, chairman of Serum Institute of India (SII) on Friday.
Read More
Difficulties in getting licences, permissions for vaccine lessened during
Updated : 4 years, 7 months ago IST
New Delhi [India], August 13 (ANI): Serum Institute of India's chairman and managing director Cyrus Poonawalla on Friday praised the Narendra Modi government for bringing reforms in the vaccine industry for getting permissions and licences on priority and said difficulties to get licenses an
Read More
Health Minister Mansukh Mandaviya meets Adar Poonawalla, discusses COVID v
Updated : 4 years, 7 months ago IST
New Delhi [India], August 6 (ANI): In order to ramp up COVID-19 vaccine supply in the country, Union Health Minister Mansukh Mandaviya on Friday met Serum Institute of India (SII) CEO Adar Poonawalla in the national capital and held a discussion over the supply of Covishield vaccine.
Read More
CII to work with Serum Institute to expand vaccination across small towns,
Updated : 4 years, 8 months ago IST
New Delhi [India], July 30 (ANI): The Confederation of Indian Industry (CII) has entered into an agreement with the Serum Institute of India (SII) to accelerate COVID-19 vaccination in partnership with industry, including healthcare providers.
Read More
France includes Covishield in list of approved vaccines for travel to coun
Updated : 4 years, 8 months ago IST
Paris [France), July 19 (ANI): France on Monday included Covishield produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University in the list of approved vaccines for travel to the country.
Read More
Good news for travellers that Covishield recognised by 16 European nations
Updated : 4 years, 8 months ago IST
New Delhi [India], July 17 (ANI): Chief Executive Officer (CEO) and owner of the Serum Institute of India (SII) on Saturday said that it was good news for international travellers that Covishield, the Indian version of the Oxford-Astrazeneca vaccine was now recognised and accepted by 16 E
Read More